The International Journal of Applied Pharmaceutics, (IJAP), the publication of the Innovare Academic Sciences, has reached yet another milestone in its academic journey. The journal’s CiteScore has risen from 1.7 in 2024 to 1.9 in 2025, indicating its growing influence and citation impact in the global pharmaceutical research community. In addition, the journal is in the 60th percentile, indicating improved visibility, quality, and recognition amongst journals in the pharmaceutical sciences.
A Testament to Research Excellence.
The journal’s growing CiteScore indicates its popularity, as well as the quality and rigor of the research it publishes. CiteScore is defined as the average number of citations received by a journal from documents published in Scopus over a four-year period. A rise from 1.7 to 1.9 means articles published in IJAP are receiving more attention and citations from researchers around the globe.
Growing Global Recognition.
The increase in percentile ranking to 60% indicates the journal’s improving position within its subject area. This result shows that IJAP is better than a larger number of journals in its subject field than ever before. The development is due to the efforts of the authors, reviewers, members of the editorial board and readers towards maintaining the scientific quality of the journal.
Scope and Impact.
International Journal of Applied Pharmaceutics is an open access and peer-reviewed journal that publishes original research, review articles and short communications on a variety of topics related to pharmaceutical science, including, but not limited to.
- Novel drug delivery systems.
- Nanotechnology and nanocarrier-based preparations.
- Drug metabolism study.
- Studying drugs and designing experience.
- Precision and effective therapeutic administration.
- Drug design process.
- Drug delivery systems based on polymer.
- Studies relating to drugs and poisons.
The journal is a valuable platform for researchers, academicians and researchers who want to publish new findings in pharmaceutical sciences.
Another Leading Scopus-Indexed Journal: Asian Journal of Pharmaceutical and Clinical Research.
Along with IJAP, Innovare Academic Sciences publishes AJPCR which is well-established and Scopus indexed journal. It has gained popularity among researchers in pharmaceutical, clinical and biomedical sciences.
AJPCR has been providing an international platform for the publication of original research articles, review papers, case studies and short communications which mainly deals with.
- Pharmacotherapeutics and clinical pharmacy.
- Pharmacology & toxicology.
- Medicine Chemistry.
- Pharmaceutical research and testing.
- Medicine used in testing and mannequin experimentations.
- Medicinal plants research, natural products.
- Drug Biotechnology.
- Public Health and Health Care Research Researches
Researchers from all parts of the globe contribute to the journal and association of the journal enhances scientific knowledge by several notches through high-quality, peer-reviewed research.
The Scopus indexing helps in making the published work visible and accessible to a wider section of the international scientific community.
Commitment to Quality Publishing.
Published by Innovare Academic Sciences, both IJAP and AJPCR are constantly strengthening editorial processes, peer-review standards and international visibility. Inclusion in Scopus and other major indexes has enhanced their access and credibility both domestically and internationally.
Using stringent peer review, ethical publishing and scientific excellence as their guiding principles, these journals provide a trusted platform for researchers to share innovative findings and promote growth in pharmaceutical and clinical sciences.
Looking Ahead.
The fact that the CiteScore and percentile of IJAP have improved is a good sign. To continue the success of the Asian Journal of Pharmaceutical and Clinical Research, these milestones are indicative of Innovare Academic Sciences that supports impactful research and academic excellence.
We are thankful to authors, reviewers, editorial board members and readers for their contributions which have brought tremendous success to Innovare Academic Sciences. Both journals will have even greater successes in the years to come along with continued support from the global research community.
For more information, visit.
International Journal of Applied Pharmaceutics (IJAP).
Asian Journal of Pharmaceutical and Clinical Research (AJPCR)
FAQs
1. What is the International Journal of Applied Pharmaceutics (IJAP)?
The International Journal of Applied Pharmaceutics (IJAP) is a peer-reviewed, open-access journal published by Innovare Academic Sciences that focuses on pharmaceutical research, drug delivery systems, pharmaceutical technology, pharmacology, pharmaceutical analysis, and related disciplines.
2. Is IJAP indexed in Scopus?
Yes. The International Journal of Applied Pharmaceutics is indexed in Scopus, one of the world’s leading abstract and citation databases for peer-reviewed literature.
3. What is the latest CiteScore of IJAP?
According to the latest Scopus metrics, IJAP’s CiteScore increased from 1.7 in 2024 to 1.9 in 2025, demonstrating improved citation performance and research impact.
4. What does a CiteScore of 1.9 mean?
A CiteScore of 1.9 indicates that, on average, articles published in the journal received 1.9 citations during the Scopus evaluation period, reflecting the journal’s growing influence in pharmaceutical sciences.
5. What is IJAP’s current percentile ranking?
IJAP achieved a 60th percentile ranking in 2025, indicating that it performs better than approximately 60% of journals within its subject category.
6. Why is the increase in CiteScore important?
An increasing CiteScore reflects greater visibility, readership, and citation of published research. It is often considered an indicator of a journal’s academic impact and reputation.
7. What types of articles does IJAP publish?
IJAP publishes:
- Original Research Articles
- Review Articles
- Short Communications
- Method Development Studies
- Pharmaceutical Technology Research
- Drug Delivery and Nanotechnology Research
8. Is IJAP an open-access journal?
Yes. IJAP follows an open-access publishing model, allowing researchers and readers worldwide to access published articles freely.
9. Who publishes IJAP?
IJAP is published by Innovare Academic Sciences, an international academic publisher dedicated to advancing scientific research and scholarly communication.
10. How does IJAP ensure publication quality?
The journal maintains quality through:
- Rigorous peer review
- Editorial screening
- Ethical publishing standards
- Expert editorial board oversight
- Compliance with international publication guidelines
11. Who can submit manuscripts to IJAP?
Researchers, academicians, industry professionals, healthcare scientists, and postgraduate scholars working in pharmaceutical and allied sciences are encouraged to submit their work.
12. What research areas are covered by IJAP?
The journal covers:
- Pharmaceutics
- Drug Delivery Systems
- Nanomedicine
- Pharmaceutical Analysis
- Pharmacokinetics
- Pharmacology
- Pharmaceutical Biotechnology
- Herbal and Natural Product Research
- Clinical Pharmacy
- Novel Formulation Development
13. How can authors submit their manuscripts?
Authors can submit manuscripts through the journal’s online submission system available on the official journal website.
14. What factors contributed to IJAP’s improved Scopus metrics?
The improvement can be attributed to:
- High-quality research publications
- Increased international citations
- Enhanced visibility of published articles
- Strong editorial and peer-review processes
- Growing global author participation
15. Where can I learn more about IJAP?
Visit the official journal website to explore published articles, author guidelines, indexing information, and submission details.
Website: https://journals.innovareacademics.in/index.php/ijap
Disclaimer: Before publication, verify these latest Scopus metrics from the official Scopus Source Details page to ensure complete accuracy.